Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

NCT02825160 · clinicaltrials.gov ↗

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: Ventavis (Iloprost, BAYQ6256)

Sponsor

Bayer